To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

bluebird bio appoints David Davidson as chief medical officer

By Chris Reidy

 |  Globe Staff  

  February 16, 2012

bluebird bio, a Cambridge company that eschews capital letters while focusing on gene therapies for severe genetic disorders, announced the appointment of David M. Davidson, M.D., to the role of chief medical officer. Before joining bluebird bio, Davidson served as a senior medical director at Genzyme Corp., where he led clinical research for programs for more than a decade. Bluebird bio’s therapy-development approach uses stem cells harvested from the patient’s bone marrow into which a healthy version of the disease-causing gene is inserted.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help